New hope for HTLV-1: drug combo trial targets virus and symptoms
Disease control
Not yet recruiting
This study tests whether the drug dolutegravir, alone or with tenofovir, can lower the amount of HTLV-1 virus in the blood and improve symptoms like pain, stiffness, and muscle weakness. About 146 adults with HTLV-1 infection and related health problems will take part. The goal i…
Phase: PHASE2 • Sponsor: Carlos Brites • Aim: Disease control
Last updated May 05, 2026 11:56 UTC